Literature DB >> 28710667

Parkinson's disease with mild cognitive impairment: severe cortical thinning antedates dementia.

Carmen Gasca-Salas1,2,3, Daniel García-Lorenzo4, David Garcia-Garcia1,2,5,6, Pedro Clavero1,2,7, José A Obeso1,2,3, Stephane Lehericy4, María C Rodríguez-Oroz8,9,10,11.   

Abstract

Mild cognitive impairment (MCI) in Parkinson's disease (PD) is a risk factor for dementia and thus, it is of interest to elucidate if specific patterns of atrophy in PD-MCI patients are associated with a higher risk of developing dementia. We aim to define pattern(s) of regional atrophy in PD-MCI patients who developed dementia during 31 months of follow-up using cortical thickness analysis Twenty-three PD-MCI patients and 18 controls underwent brain MRI and completed a neuropsychological examination at baseline, PD-MCI patients were followed after a 31 month follow-up in order to assess their progression to dementia. At follow up, 8 PD-MCI patients had converted to dementia (PD-MCI converters) whereas 15 remained as PD-MCI (PD-MCI non-converters). All patients were at least 60 years old and suffered PD ≥ 10 years. There were no baseline differences between the two groups of patients in clinical and neuropsychological variables. The cortex of PD-MCI converters was thinner than that of PD-MCI non-converters, bilaterally in the frontal, insula and the left middle temporal areas, also displaying a more widespread pattern of cortical thinning relative to the controls. This study shows that aged and long-term PD patients with MCI who convert to dementia in the short-mid term suffer a thinning of the cortex in several areas (frontal cortex, and middle temporal lobe and insula), even when their cognitive impairment was similar to that of PD-MCI non-converters. Thus, MRI analysis of cortical thickness may represent a useful measure to identify PD-MCI patients at a higher risk of developing dementia.

Entities:  

Keywords:  Cortical thickness; Dementia; Mild cognitive impairment; Parkinson’s disease

Mesh:

Year:  2019        PMID: 28710667     DOI: 10.1007/s11682-017-9751-6

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  8 in total

1.  Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.

Authors:  Seok Jong Chung; Han Soo Yoo; Yang Hyun Lee; Hye Sun Lee; Byoung Seok Ye; Young H Sohn; Hunki Kwon; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2019-05-14       Impact factor: 5.038

Review 2.  Structural and Functional Brain Patterns of Non-Motor Syndromes in Parkinson's Disease.

Authors:  Tino Prell
Journal:  Front Neurol       Date:  2018-03-12       Impact factor: 4.003

3.  Cortical thinning in dementia with Lewy bodies and Parkinson disease dementia.

Authors:  Sean J Colloby; Rosie Watson; Andrew M Blamire; John T O'Brien; John-Paul Taylor
Journal:  Aust N Z J Psychiatry       Date:  2019-11-07       Impact factor: 5.744

Review 4.  Can neuroimaging predict dementia in Parkinson's disease?

Authors:  Juliette H Lanskey; Peter McColgan; Anette E Schrag; Julio Acosta-Cabronero; Geraint Rees; Huw R Morris; Rimona S Weil
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

Review 5.  Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease.

Authors:  Sanskriti Sasikumar; Antonio P Strafella
Journal:  Front Neurol       Date:  2020-01-31       Impact factor: 4.003

Review 6.  Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition.

Authors:  Lenka Krajcovicova; Patricia Klobusiakova; Irena Rektorova
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

7.  Cortical thickness in Parkinson disease: A coordinate-based meta-analysis.

Authors:  LiQin Sheng; PanWen Zhao; HaiRong Ma; Joaquim Radua; ZhongQuan Yi; YuanYuan Shi; JianGuo Zhong; ZhenYu Dai; PingLei Pan
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

Review 8.  The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease.

Authors:  Hailing Liu; Bin Deng; Fen Xie; Xiaohua Yang; Zhenchao Xie; Yonghua Chen; Zhi Yang; Xiyan Huang; Shuzhen Zhu; Qing Wang
Journal:  Ann Clin Transl Neurol       Date:  2021-07-26       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.